MENU
JSPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Jasper Therapeutics (JSPR) Ownership - Who owns Jasper Therapeutics?
Profile
Industry
N/A
Address
2200 Bridge Parkway
Phone
+1 650 549-1400
Employees
45
Web
https://www.jaspertherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
321.78M
P/E Ratio
N/A
Total Cash
92.5M
Projected Growth
N/A
Total Debt
2.07M
Revenue
N/A
Risk (Beta)
4.17
Dividend Yield
N/A
Total Cash/Share
6.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
JSPR
Capitalization
322M
P/E Ratio
N/A
Risk (Beta)
4.17
Dividend Yield
N/A
Total Cash
92.5M
Total Cash/Share
6.17
Total Debt
2.07M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
83.7M
P/B Ratio
4.02
Cash Flow
N/A
Earnings
-4.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
7.61
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-67.27M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-60.56
Shares Held By Institutions
409M
Shares Outstanding - Current
15M
Total Liabilities
15.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
184.537
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2200 Bridge Parkway
Phone
+1 650 549-1400
Employees
45
Web
https://www.jaspertherapeutics.com